Publication Name	World Journal of Hepatology
Manuscript ID	39314
Country	United States

Received	2018-04-11 06:34
Peer-Review Started	2018-04-11 07:53
To Make the First Decision	2018-05-02 03:41
Return for Revision	2018-05-03 06:23
Revised	2018-05-10 04:46
Second Decision	2018-05-22 09:49
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-05-24 03:37
Articles in Press	2018-05-24 03:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-10-19 00:23
Publish the Manuscript Online	2018-10-27 04:40

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Era of direct acting anti-viral agents for the treatment of hepatitis C
Manuscript Source	Unsolicited Manuscript
All Author List	Monjur Ahmed
ORCID	Author(s) ORCID Number Monjur Ahmed http://orcid.org/0000-0003-0515-9224
Funding Agency and Grant Number
Corresponding Author	Monjur Ahmed, FACG, FACP, MD, Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Thomas Jefferson University, 132 South 10th Street, Suite 468, Main Building, Philadelphia, PA 19107, United States. monjur.ahmed@jefferson.edu
Key Words	Direct acting anti-viral agents; Hepatitis C virus infection; Post-liver transplant; Hepatitis C virus/human immunodeficiency virus co-infection
Core Tip	Treatment of hepatitis C has now become much easy and simple with the advent of direct acting anti-viral agents (DAAs) against hepatitis C virus (HCV). Although the DAAs are highly effective in eradicating HCV infection, they have different mechanisms of action, side effects, resistance factors and drug-drug interactions. The treatment also varies in special situations like HCV/ human immunodeficiency virus co-infection and post-liver transplant patients. Physicians treating patients with HCV infection should have a clear knowledge about the DAAs as well as the current guidelines.
Publish Date	2018-10-27 04:40
Citation	Ahmed M. Era of direct acting anti-viral agents for the treatment of hepatitis C. World J Hepatol 2018; 10(10): 670-684
URL	http://www.wjgnet.com/1948-5182/full/v10/i10/670.htm
DOI	http://dx.doi.org/10.4254/wjh.v10.i10.670

Full Article (PDF)	WJH-10-670.pdf
Full Article (Word)	WJH-10-670.doc
Manuscript File	39314-Review.docx
Answering Reviewers	39314-Answering reviewers.pdf
Audio Core Tip	39314-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	39314-Conflict-of-interest statement.pdf
Copyright License Agreement	39314-Copyright assignment.pdf
Peer-review Report	39314-Peer-review(s).pdf
Scientific Misconduct Check	39314-Scientific misconduct check.pdf
Scientific Editor Work List	39314-Scientific editor work list.pdf